News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
BIO’s Dr. McMurry-Heath Calls Foreign Price…
Washington, DC (November 20, 2020) – Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose…
BIO’s Dr. Michelle McMurry-Heath Congratulates…
"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes…
New Strategic Vision for Biotechnology…
The Biotechnology Innovation Organization (BIO) today announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds. Announcing the new vision, mission and…
Letters, Testimony, & Comments
BIO Comments on FDA Draft Guidance, Drug-Drug…
On November 9, BIO submitted comments on the FDA Draft Guidance, Drug-Drug Interaction Assessment for Therapeutic Proteins. In the comments, BIO thanks the FDA for the opportunity to submit comments but requests that the Guidance include a…
BIO Submits Comments on NMPA Draft Technical…
On August 6, BIO submitted comments on the NMPA Draft Technical Guideline on Clinical Trials of Cellular Immunotherapy Products. In the comments, BIO thanks NMPA for the opportunity to submit comments but argues for a more robust commenting period…
Patient Reported Outcomes: BIO Comments on FDA…
October 30, 2020 Re: Docket No. FDA–2020-D-1564: FDA Draft Guidance, Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation. Dear Sir/Madam: The Biotechnology…
Amicus Briefs
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
BIO Files Amicus Brief on Case Addressing…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Blog Posts
Vaccine
November 20, 2020
Even in a global pandemic, there’s one thing that hasn’t changed: the need to get a flu shot. In fact, receiving a flu shot is more important than ever to avoid burdening the hospitals and health care professionals…
BTN-MTC_Researchers-DNA-364x210
November 19, 2020
In early October, it was announced Jennifer Doudna and Emmanuelle Charpentier were being awarded the prestigious Nobel Prize in Chemistry for developing the CRISPR Cas-9 system, a simple yet powerful tool for editing…
This Major Breakthrough Could Help Improve Global Food Supply
November 18, 2020
Do you have questions about GMOs? If you do, you’re not alone. Many people find that they need to visit multiple sources or decipher scientific jargon for complete, accurate answers. Our new video series will…